Eli Lilly v Genentech
Eli Lilly v Genentech: the question of SPCs based on third party MAs is referred to the CJEU.
Read more
Computer-implemented simulations – referral to the EBoA
Likely to affect the patentability of ‘simulation’ methods, Howard Read explores the issues behind a European Patent Office (EPO) referral to the Enlarged Board of Appeal (EBA).
Read more
Patentability of products obtained from biological processes
After years of controversy, the Technical Board of Appeal (TBA) of the EPO has recently decided that products obtained by essentially biological processes can be patent protected (T1063/18).
Read more
Missing the target with functional claim language
What’s the problem with ‘functional limitations’?
Read moreNew Guidance on Patent Eligibility in the USA
Read moreA tale of broccoli, tomatoes and peppers
Read moreWarner-Lambert feels the pain in the Supreme Court
Read moreSPC you later to drug-device combinations
Read moreA Patent Guide to Christmas Day
Read moreWomen in IP – Flexible working and career breaks
Read moreMapping the commercial landscape for quantum technologies
Read more
